Breaking
Friday, June 19, 2026

Press Releases

🌏 NMPA

NMPA news and analysis for pharmaceutical BD, investment, and market access

Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.

Showing 1–12 of 97 articles

Quick answer

Track 97 NMPA pharmaceutical press releases and corporate announcements — product launches, trial updates, partnerships, and regulatory milestones. Each story links to company profiles, pipeline programs, and related market intelligence for BD and investor due diligence.

High impact NewsMay 5, 2026

Cryoport Q1 2026 Results: Revenue Jumps 26% Supporting Record 766 Clinical Trials and 21 Commercial Cell Gene Therapies

2 min

Dr. Priya Sharma
High impact NewsMay 5, 2026

Lunai Bioworks Raises $20 Million to Acquire CNS Drug Delivery Technology for Alzheimer's Treatment

2 min

Dr. Yuki Tanaka
High impact NewsMay 4, 2026

Telix Pharmaceuticals' TLX250-Px Shows Promise for Diagnosing Multiple Kidney Cancer Types Beyond Clear Cell RCC

2 min

Arjun Menon
High impact NewsMay 4, 2026

Mifepristone Access Continues Under Supreme Court Hold as Planned Parenthood Responds to 5th Circuit Ruling

Reproductive Health/Medical Abortion · 3 min

Dr. Priya Sharma
High impact NewsMay 4, 2026

SPONTAN Phase II Data Shows 10-Minute Onset Time, Meets FDA Requirements for Erectile Dysfunction Treatment

FDA · 2 min

Dr. Grace Tan
High impact NewsMay 4, 2026

Ironwood Pharmaceuticals Survey Reveals Critical Gaps in Short Bowel Syndrome TPN Treatment at DDW 2026

2 min

Hiroshi Sato
Critical impact NewsMay 4, 2026

Arrowhead Pharmaceuticals Receives TGA Approval for REDEMPLO (Plozasiran) in Australia for Rare Genetic Disorder

2 min

Dr. Priya Sharma
High impact NewsMay 4, 2026

ROIS Expands to US Market as Global CDMO with FDA Approval for Injectable Drug Manufacturing

2 min

Arjun Menon
High impact NewsMay 4, 2026

FDA Approves Travere's FILSPARI for FSGS Treatment in Adults and Children 8+

2 min

Isabella Cruz
Critical impact NewsMay 4, 2026

UCB Acquires Candid Therapeutics for $2.2 Billion, Expanding T-Cell Engager Platform for Autoimmune Diseases

Autoimmune and inflammatory diseases · 3 min

Kenji Watanabe
High impact NewsMay 3, 2026

a2 Milk Company Recalls Three Batches of a2 Platinum Infant Formula Due to Health Risk Concerns

Infant Nutrition · 3 min

Dr. Mei Lin
High impact NewsMay 2, 2026

Vector Science & Therapeutics Files Patent for Microneedle Catheter Platform for Cancer Drug Delivery

2 min

Dr. Mei Lin

Frequently asked questions

What counts as a press release on NovaPharmaNews?

Corporate announcements from pharma and biotech sponsors — FDA/EMA milestones, trial initiations, financing, licensing deals, and product launches — tagged to the press releases topic and cross-linked to company entity profiles where available.

How is this different from drug approval news?

Drug approval coverage focuses on regulatory decisions and label changes. Press releases capture sponsor-issued announcements, which may precede or supplement formal agency actions.

Can I find press releases by company?

Open any article to see linked company names, then follow through to the company directory profile for pipeline, drugs, patents, and related news.